BSc Nursing, third semester, pathogenic microorganism, nodes. Could-- You could start with the Streptococcus. Staphylococcus.
Reading File
Now let me search the library for Streptococcus and Staphylococcus content relevant to BSc Nursing pathogenic microbiology.
Finding Sources
Finding Sources
Medical Microbiology 9e is the best source here. Let me read both sections in parallel.
Reading File
Reading File
Good - I have rich content. Let me now read the Streptococcus pyogenes section and also get the Staphylococcus coagulase-negative and the classification/overview sections.
Reading File
Reading File
I now have comprehensive content from Medical Microbiology 9e. Let me compile a thorough, well-structured answer for a BSc Nursing 3rd semester student.
Pathogenic Microorganisms: Staphylococcus & Streptococcus
BSc Nursing - 3rd Semester | Microbiology
STAPHYLOCOCCUS
Classification & Basic Characteristics
Staphylococci are Gram-positive cocci arranged in irregular grape-like clusters ("staphyle" = bunch of grapes in Greek). They are:
- Catalase-positive (distinguishes them from Streptococcus)
- Non-motile, non-spore-forming
- Facultative anaerobes
- Can survive on dry surfaces for long periods due to a thick peptidoglycan cell wall and no outer membrane
Key species of clinical importance:
| Species | Coagulase | Clinical Significance |
|---|---|---|
| S. aureus | Positive | Most virulent; major pathogen |
| S. epidermidis | Negative | Opportunistic; catheter/implant infections |
| S. saprophyticus | Negative | UTIs in young women |
Staphylococcus aureus
Virulence Factors
Structural components:
- Protein A - binds IgG antibodies backwards (Fc region), blocking phagocytosis
- Capsule - resists phagocytosis
- Peptidoglycan - resists drying; triggers inflammation
- Teichoic acid - helps adherence to mucosal surfaces
Toxins:
| Toxin | Action | Disease |
|---|---|---|
| Exfoliative toxins (A & B) | Cleave desmoglein-1 in skin | Staphylococcal Scalded Skin Syndrome (SSSS) |
| Enterotoxins (A-E, etc.) | Heat-stable superantigens | Food poisoning |
| Toxic Shock Syndrome Toxin-1 (TSST-1) | Superantigen; massive cytokine release | Toxic Shock Syndrome |
| Panton-Valentine Leukocidin (PVL) | Destroys leukocytes | Necrotizing pneumonia, severe furunculosis |
| Alpha-toxin (α-hemolysin) | Pore-forming; lyses RBCs & other cells | Tissue destruction |
Enzymes:
| Enzyme | Action |
|---|---|
| Coagulase | Converts fibrinogen to fibrin; "walls off" infection (key ID test for S. aureus) |
| Hyaluronidase | Breaks down connective tissue; spreads infection |
| Staphylokinase | Dissolves fibrin clots |
| DNase | Breaks down DNA |
| Lipase | Helps colonize sebaceous skin areas |
Epidemiology
- Normal flora on human skin and nasal mucosa (~30% of population are nasal carriers)
- Spread by direct contact or contaminated fomites (bed linens, clothing)
- MRSA (Methicillin-Resistant S. aureus) is now the most common cause of community-acquired skin and soft-tissue infections - a major public health concern worldwide
Risk groups:
- Infants (SSSS)
- Surgical patients, patients with catheters/prostheses
- IV drug users
- Immunocompromised patients
Diseases Caused by S. aureus
1. Toxin-mediated diseases:
- Scalded Skin Syndrome (SSSS) - mainly in neonates and infants; diffuse bullous desquamation; no organisms in the blisters
- Food Poisoning - rapid onset (1-6 hrs) vomiting, diarrhea, abdominal cramps after ingestion of pre-formed heat-stable enterotoxin; resolves within 24 hrs
- Toxic Shock Syndrome (TSS) - fever, hypotension, diffuse erythematous rash, multi-organ failure; associated with tampon use or wound infections
2. Suppurative (pus-forming) infections:
- Impetigo - pus-filled vesicles on erythematous base
- Folliculitis - infection of hair follicles
- Furuncles (boils) - large, painful, pus-filled nodules
- Carbuncles - coalescence of furuncles extending into subcutaneous tissue; associated with systemic signs (fever, bacteremia)
3. Systemic infections:
- Bacteremia and Endocarditis - bacterial seeding of heart valves
- Pneumonia - especially post-influenza; severe necrotizing form possible
- Osteomyelitis - destruction of bone (especially metaphysis of long bones in children)
- Septic arthritis - purulent joint effusion
- Meningitis - especially in patients with shunts
Diagnosis
- Gram stain - Gram-positive cocci in clusters
- Culture - grows rapidly on non-selective media; selective media: mannitol-salt agar (ferments mannitol; colonies turn yellow), chromogenic agar
- Coagulase test - positive = S. aureus (tube/slide test)
- NAAT (nucleic acid amplification) - screening for MRSA carriage
- Catalase test - positive (bubbles with H₂O₂); distinguishes from Streptococcus
Treatment
| Infection Type | Treatment |
|---|---|
| Localized (abscess) | Incision and drainage (I&D) |
| Non-MRSA systemic | Beta-lactams (oxacillin, nafcillin) |
| MRSA | Vancomycin (IV) - drug of choice; alternatives: daptomycin, linezolid |
| Oral MRSA | Trimethoprim-sulfamethoxazole (TMP-SMX), doxycycline, clindamycin, linezolid |
| Food poisoning | Symptomatic only |
STREPTOCOCCUS
Classification
Lancefield grouping (based on cell wall carbohydrate antigen):
- Group A = S. pyogenes
- Group B = S. agalactiae
- Group D = Enterococcus (now reclassified)
Hemolysis pattern on blood agar:
| Hemolysis | Pattern | Example |
|---|---|---|
| Beta (β) | Complete - clear zone | S. pyogenes (Group A), S. agalactiae (Group B) |
| Alpha (α) | Partial - green zone (incomplete lysis) | S. pneumoniae, viridans streptococci |
| Gamma (γ) | No hemolysis | Enterococcus |
Streptococcus pyogenes (Group A Streptococcus - GAS)
Basic Features
- Spherical cocci, 1-2 µm diameter
- Arranged in short chains in clinical specimens; longer chains in liquid media
- Beta-hemolytic on blood agar
- Catalase-negative (distinguishes from Staphylococcus)
- Bacitracin sensitive (key lab test - inhibited by bacitracin)
Virulence Factors
Structural:
- M protein - major virulence factor; anti-phagocytic; over 200 serotypes based on emm gene; class I M proteins are associated with rheumatic fever
- Hyaluronic acid capsule - antigenically similar to human connective tissue, so not recognized as foreign; anti-phagocytic
- Lipoteichoic acid + F protein - adhere to fibronectin on host cells
- Group A carbohydrate (Lancefield antigen) - N-acetylglucosamine + rhamnose dimer; used for classification
Toxins:
- Erythrogenic (pyrogenic) toxins (SPE A, B, C) - superantigens; cause the scarlet fever rash; SPE A is associated with toxic shock-like syndrome
- Streptolysin O (SLO) - oxygen-labile; lyses RBCs and leukocytes; immunogenic - antibodies (ASO titer) used diagnostically
- Streptolysin S (SLS) - oxygen-stable; responsible for the beta-hemolysis seen on blood agar plates
Enzymes:
- Streptokinase (fibrinolysin) - dissolves fibrin clots; aids spread
- Hyaluronidase - "spreading factor"; breaks down connective tissue
- DNase (streptodornase) - liquefies pus; aids spread
- C5a peptidase - destroys complement component C5a, impairing neutrophil recruitment
Diseases Caused by S. pyogenes
Suppurative (pus-forming) diseases:
- Pharyngitis ("strep throat") - most common bacterial pharyngitis; tonsillar exudates, fever, no cough
- Impetigo - honey-crusted skin lesion; more common in children
- Cellulitis - spreading skin/soft tissue infection
- Erysipelas - superficial skin infection with sharp raised borders; typically on face
- Necrotizing fasciitis - "flesh-eating bacteria"; rapid destruction of fascia and muscle; high mortality
- Scarlet fever - pharyngitis + strawberry tongue + diffuse sandpaper rash (from pyrogenic toxin)
Nonsuppurative (post-infectious/immunological) complications:
- Rheumatic Fever - occurs 2-4 weeks after pharyngitis; involves heart (carditis), joints (polyarthritis), skin (erythema marginatum, subcutaneous nodules), and CNS (Sydenham's chorea); caused by molecular mimicry between M protein and cardiac tissue
- Post-streptococcal glomerulonephritis (PSGN) - occurs 1-3 weeks after pharyngitis or skin infection; immune complex deposition in glomeruli; hematuria, proteinuria, hypertension
Diagnosis
- Gram stain - Gram-positive cocci in chains
- Culture on blood agar - beta-hemolytic colonies
- Rapid antigen detection test (RADT) - detects Group A carbohydrate antigen; quick but less sensitive
- Throat culture - gold standard for pharyngitis
- ASO titer (Anti-Streptolysin O) - elevated in post-streptococcal disease (rheumatic fever, PSGN)
Treatment
- Penicillin G (or V) - drug of choice; S. pyogenes has never developed resistance to penicillin
- Amoxicillin - commonly used orally
- Azithromycin or clindamycin - for penicillin-allergic patients
- Importance of completing the course - to prevent rheumatic fever
Streptococcus pneumoniae (Pneumococcus)
Basic Features
- Elongated diplococci (pairs) arranged in short chains; lancet-shaped
- Alpha-hemolytic on blood agar (green zone)
- Optochin sensitive (key lab test) and bile soluble
- Identified by: catalase negative, optochin susceptibility, bile solubility
Virulence Factors
- Polysaccharide capsule - most important; >90 serotypes; anti-phagocytic
- Pneumolysin - lyses host cells and inhibits complement
- IgA protease - cleaves secretory IgA; helps colonize respiratory mucosa
- Teichoic acid (C-polysaccharide) - activates complement; triggers inflammation
- Surface adhesins - help colonize nasopharynx
Diseases
- Lobar pneumonia (most common cause in adults)
- Meningitis (most common cause in adults; also in children after Hib vaccine)
- Otitis media (most common cause in children)
- Sinusitis
- Bacteremia/Sepsis - fulminant in asplenic patients
Diagnosis
- Gram stain: Gram-positive diplococci (lancet-shaped)
- Culture on sheep blood agar (enriched media)
- Optochin sensitivity test
- Quellung reaction - capsule swelling with specific antibody (gold standard for serotyping)
- Antigen tests for C polysaccharide (CSF - highly sensitive)
- NAAT for meningitis
Treatment & Prevention
- Penicillin (if susceptible); high-dose amoxicillin
- Cephalosporins for resistant strains; vancomycin for severe/resistant meningitis
- Vaccines: PCV13 (13-valent conjugate, for children) and PPSV23 (23-valent polysaccharide, for adults >65 and high-risk groups)
Streptococcus agalactiae (Group B Streptococcus - GBS)
- Beta-hemolytic, Group B Lancefield antigen
- CAMP test positive (key lab test) - enhances RBC lysis in presence of S. aureus
- Hippurate hydrolysis positive
- Major pathogen in neonates and pregnant women
Diseases:
- Neonatal sepsis and meningitis - early-onset (within 7 days) or late-onset
- Postpartum endometritis in mothers
- UTI in pregnant women
Treatment: Penicillin; for high-risk pregnancies, intrapartum penicillin is given at least 4 hours before delivery
QUICK COMPARISON TABLE
| Feature | Staphylococcus aureus | Streptococcus pyogenes | S. pneumoniae |
|---|---|---|---|
| Shape/Arrangement | Clusters | Chains | Pairs (diplococci) |
| Gram stain | +ve | +ve | +ve |
| Catalase | Positive | Negative | Negative |
| Hemolysis | Beta | Beta | Alpha |
| Key enzyme | Coagulase (+) | Coagulase (-) | - |
| Key ID test | Coagulase test | Bacitracin sensitive | Optochin sensitive |
| Key toxin | TSST-1, exfoliatin | Streptolysin O/S | Pneumolysin |
| Drug of choice | Vancomycin (MRSA) | Penicillin G | Penicillin |
NURSING RELEVANCE - KEY POINTS
- Infection control - MRSA is spread by contact; hand hygiene and standard precautions are the most effective prevention
- ASO titer monitoring - nurses should recognize elevated ASO titer as a marker for post-streptococcal complications
- Completing antibiotic courses - especially for Strep throat, to prevent rheumatic fever
- Neonatal care - GBS screening of pregnant women (vaginal/rectal swab at 35-37 weeks) and prophylactic penicillin in labor
- SSSS in infants - handle with care; skin barrier is compromised; prevent secondary infections
- Vaccine counseling - educate patients on pneumococcal vaccines (especially elderly, asplenic, immunocompromised)
Sources: Medical Microbiology 9e (Murray et al.), p. 1909-2700; Goldman-Cecil Medicine.
This is a shared conversation. Sign in to Orris to start your own chat.